Subcutaneous Delivery Equipment & Supplies
5 equipment items found
by:Starton Therapeutics based inParamus, NEW JERSEY (USA)
STAR-LLD is in development in two continuous delivery systems: subcutaneous and transdermal. STAR-LLD is being developed to establish the only IMiD (immunomodulatory drug) approved for CLL. CLL is the most common form of leukemia. Lenalidomide has been shown to be efficacious and well tolerated in CLL previous randomized controlled trials did not obtain an ...
Manufactured by:Oval Medical Technologies Ltd. based inBeach Drive, UNITED KINGDOM
The ArQ® subcutaneous platform is built around our cyclic olefin copolymer (COC) primary drug container. It offers an autoinjector that is simple to use for the patient, with the flexibility and ability to deliver a wide range of viscosities and ...
Manufactured by:PharmaJet based inGolden, COLORADO (USA)
The Stratis Needle-free Injection System delivers accurate and consistent 0.5 ml intramuscular and subcutaneous injections to help you achieve better results with your pharma ...
Manufactured by:Celanese Corporation based inIrving, TEXAS (USA)
Celanese’s VitalDose® EVA pharmaceutical grade copolymer is an enabling technology for drug-eluting ...
by:Starton Therapeutics based inParamus, NEW JERSEY (USA)
STAR-LLD is in development in two continuous delivery systems: subcutaneous and transdermal. STAR-LLD is in development for new multiple myeloma indications for lenalidomide and achievement of superiority versus oral lenalidomide in maintenance treatment of multiple myeloma. The STAR-LLD delivery system is expected to provide significant ...